Breaking News, Trials & Filings

FDA Approves Bayer’s OC Natazia

Bayer HealthCare Pharmaceuticals received approval from the FDA for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bayer HealthCare Pharmaceuticals received approval from the FDA for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy. Natazia is the first oral contraceptive that contains a synthetic estrogen called estradiol valerate, and a progestin called dienogest. The drug is expected to be available in the summer.

“Every woman’s body reacts differently to hormones, so it is important that they have a choice in birth control options,” said Anita Nelson, MD, professor of obstetrics and gynecology at the Harbor-UCLA Medical Center, Torrance, California.”Natazia may be a good option for women to consider when making a decision with their healthcare provider about which birth control option is right for them.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters